← Leaderboards
Eleanor Y Chen
Brigham And Women'S Hospital
$2,252,342
Attributed
$2,252,342
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $462.5K · FY2012–20$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,252,342 · 2
By mechanism
R01$1,557,902 · 1
K08$694,440 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Andrew Michael Siedlecki$795,443
- David O Ferguson$7,578,383
- Jeffrey A. Linder$3,572,994
- Nader Najafian$992,939
- Stephanie Elizabeth Chiuve$967,508
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPlayLoss Of FunctionMalignant NeoplasmsTumorPathway InteractionsEmbryonal RhabdomyosarcomaLeadMolecularRhabdomyosarcomaSelf-RenewalSoft TissueTumor ProgressionChildBaseCell LineInnovationInsightPathologicPublic Health RelevanceCell Cycle ProgressionCareerAnatomyApplications Grants
Grant awards (11)
Characterizing Histone Deacetylases in Rhabdomyosarcoma$318,077
R01 · FY2020 · CA · contact PI
Characterizing Histone Deacetylases in Rhabdomyosarcoma$308,533
R01 · FY2019 · CA · contact PI
Characterizing Histone Deacetylases in Rhabdomyosarcoma$318,077
R01 · FY2018 · CA · contact PI
Characterizing Histone Deacetylases in Rhabdomyosarcoma$318,077
R01 · FY2017 · CA · contact PI
Characterizing Histone Deacetylases in Rhabdomyosarcoma$295,138
R01 · FY2016 · CA · contact PI
Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.$167,400
K08 · FY2016 · AR · contact PI
Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.$131,760
K08 · FY2015 · AR · contact PI
Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.$131,760
K08 · FY2014 · AR · contact PI
Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.$106,920
K08 · FY2013 · AR · contact PI
Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.$24,840
K08 · FY2013 · AR · contact PI
Druggable Pathways Regulating Self-Renewal in Muscle and Rhabdomyosarcoma.$131,760
K08 · FY2012 · AR · contact PI